SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Analysts at Scotiabank lowered their FY2025 earnings estimates for SNC-Lavalin Group in a research report issued to clients and investors on Wednesday, March 19th. Scotiabank analyst J. Goldman now expects that the company will earn $2.89 per share for the year, down from their previous forecast of $3.08. Scotiabank also issued estimates for SNC-Lavalin Group’s FY2026 earnings at $3.69 EPS.
Separately, Stifel Canada raised SNC-Lavalin Group to a “strong-buy” rating in a research report on Tuesday, February 4th.
SNC-Lavalin Group Stock Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Featured Stories
- Five stocks we like better than SNC-Lavalin Group
- Using the MarketBeat Stock Split Calculator
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- How to Evaluate a Stock Before Buying
- 3 ETFs to Ride the VIX Surge During Market Volatility
- With Risk Tolerance, One Size Does Not Fit All
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
